Skip to main content
. 2022 Dec 30;12(1):34–40. doi: 10.21037/acs-2022-urats-140

Table 2. Perioperative outcomes of the patients undertaking hybrid uniportal RATS.

Characteristics Total (n=40)
Resection range, n (%)
   Bilobectomy 1 (2.5)
   Lobectomy + wedge resection 2 (5.0)
   Segmentectomy + wedge resection 3 (7.5)
   Lobectomy 23 (57.5)
   Bronchial sleeve lobectomy 1 (2.5)
   Segmentectomy 10 (25.0)
Conversion to biportal access, n (%) 1 (2.5)
Operation duration (min), median [IQR] 76 [61–99]
Intraoperative blood loss (mL), median [IQR] 50 [50–50]
LOS (days), median [IQR] 3 [2–4]
Drainage duration (days), median [IQR] 3 [2–4]
Drainage volume (mL), median [IQR] 263 [155–491]
Postoperative complicationsa, n (%)
   Clavien-Dindo I–II 11 (27.5)b
    Pneumonia 6 (15.0)
    Transient elevation of serum creatinine 5 (12.5)
    Atrial fibrillation 2 (5.0)
   Clavien-Dindo III–IV 0 (0.0)
Administration of extra analgesic, n (%) 6 (15.0)
Readmission within 30 days, n (%) 0 (0.0)
Mortality within 30 days, n (%) 0 (0.0)

a, postoperative complications were evaluated in accordance with Clavien-Dindo classification; b, one patient experienced both transient elevation of serum creatinine and pneumonia, and another patient also experienced both transient elevation of serum creatinine and atrial fibrillation. RATS, robot-assisted thoracoscopic surgery; IQR, interquartile range; LOS, length of stay.